Sign in
4

Changes in Ownership

CytomX Therapeutics, Inc. Filed Acc 0000899243-16-020907

Director sold 13,253 shares at an average $10.09 ($133,735)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Canaan IX L.P. Director 2016-05-23 Sale −12,053 $10.10 $121,735 4,564,015 I
Canaan IX L.P. Director 2016-05-24 Sale −1,200 $10.00 $12,000 4,562,815 I
Open-market sales · 13,253 sh · avg $10.09 · $133,735
Loading xslF345X03/doc4.xml…